Medical Director for the Early Phase Cancer Research Program, Patient-Centered Research; Aurora Research Institute
Dr. Michael Thompson is medical director for the Early Phase Cancer Research Program and the Medical Co-Director of the Oncology Precision Medicine Program at the Aurora Research Institute / Advocate Aurora Health. He is an active clinical researcher whose interests include hematologic or blood cancers (lymphoma, myeloma, leukemia and myelodysplastic syndrome).
Dr. Thompson is interested in developing new treatments for all cancers, particularly early phase (Phase I and II) molecular biomarker-driven clinical trials. Dr. Thompson's work has been extensively published, and he serves as an editor or reviewer for multiple scientific publications. He is board certified in hematology and oncology, and his current advising/consultantships include: AIM Specialty Health, BMS, Celgene, Doximity, GSK, Strata Oncology, Takeda and VIA Oncology.
Programs Featuring Mike Thompson, MD, PhD, FASCO (11)